Equity
Treasury Stock
Bristol-Myers Squibb Treasury Stock decreased by 0.1% to $43.52B in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 0.2%, from $43.60B to $43.52B. Over 5 years (FY 2020 to FY 2025), Treasury Stock shows an upward trend with a 10.7% CAGR.
Analysis
StatementBalance Sheet Statement
SectionEquity
CategoryCapital Allocation
SignalContext dependent
VolatilityModerate
First reportedQ4 2014
Last reportedQ1 2026Apr 30, 2026
How to read this metric
An increase indicates active share buyback programs, often used to return capital to shareholders or offset dilution from stock-based compensation.
Detailed definition
Treasury stock represents shares that the company has repurchased from the open market and holds in its own treasury. Th...
Peer comparison
Large-cap pharma firms frequently use share repurchases as a primary method of capital allocation to support earnings per share.
Metric ID:
treasury_stockHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $28.20B | $28.57B | $31.26B | $35.19B | $35.29B | $36.41B | $38.62B | $38.81B | $39.68B | $43.08B | $43.77B | $43.70B | $43.69B | $43.68B | $43.66B | $43.60B | $43.59B | $43.59B | $43.58B | $43.52B |
| QoQ Change | — | +1.3% | +9.4% | +12.6% | +0.3% | +3.2% | +6.1% | +0.5% | +2.2% | +8.6% | +1.6% | -0.2% | -0.0% | -0.0% | -0.0% | -0.1% | -0.0% | -0.0% | -0.0% | -0.1% |
| YoY Change | — | — | — | — | +25.2% | +27.4% | +23.5% | +10.3% | +12.4% | +18.3% | +13.3% | +12.6% | +10.1% | +1.4% | -0.3% | -0.2% | -0.2% | -0.2% | -0.2% | -0.2% |
Range$28.20B – $43.77B
CAGR+9.6%
Avg YoY Growth+9.6%
Median YoY Growth+10.2%
Current Streak9 quarters decline
Treasury Stock at Other Companies
Frequently Asked Questions
- What is Bristol-Myers Squibb's treasury stock?
- Bristol-Myers Squibb (BMY) reported treasury stock of $43.52B in Q1 2026.
- How has Bristol-Myers Squibb's treasury stock changed year-over-year?
- Bristol-Myers Squibb's treasury stock decreased by 0.2% year-over-year, from $43.60B to $43.52B.
- What is the long-term trend for Bristol-Myers Squibb's treasury stock?
- Over 5 years (2020 to 2025), Bristol-Myers Squibb's treasury stock has grown at a 10.7% compound annual growth rate (CAGR), from $26.24B to $43.58B.
- What does treasury stock mean?
- Shares that the company has bought back from the market.